GET IN TOUCH

IMPORTANT MESSAGES FROM NBR

A Thank You Letter to Women in Research...

Growing up in middle America in the 1980s, Clinical Research was not exactly a hot topic around the local watering holes. The last thing...

Barbershop Talk: The Legend of "Fame City Kut n Kurl"

The name of this write-up is tied to one of the most legendary places in Canton, Ohio! I am not just saying this because this was my...

Cheers To Mental Wellness!

January is Mental Wellness month! Yet, after the holidays people often feel exhausted and far from mentally well. To make matters worse,...

Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring

Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with...

Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study

Supplemental New Drug Application (sNDA) planned for 2023 WASHINGTON, Dec. 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda)...

Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone

At the Day 15 primary endpoint, zuranolone 50 mg showed a statistically significant and clinically meaningful reduction in depressive...